Neuropathix
@neuropathix
Followers
87
Following
106
Media
9
Statuses
80
Neuropathix, Inc. | Breakthrough Therapeutics Targeting Inflammation
Doylestown, PA
Joined July 2020
@Neuropathix subsidiary @Kannalife Awarded $2.97 Million Grant from National Institute of Neurological Disorders and Stroke (NINDS) $NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #PainMonth2021
https://t.co/yykW3VsQZh
0
3
8
Exciting news! Join @Neuropathix CEO Dean Petkanas at the 7th CB1, CB2, & Cannabinoid Drug Development Summit in Boston, Nov 18-20! Don’t miss insights on #Cannabinoids #PeripheralNeuropathy #Neuroscience #MedicalResearch #Innovation #GPCR #GPR55 #CIPN
https://t.co/42QCks98hO
0
1
5
Join @neuropathix CEO Dean Petkanas at the 7th CB1, CB2, & Cannabinoid Drug Development Summit November 18-20, 2024 | Boston, MA hosted by @HansonWade
#kannalife #gpcr #gpr55 #nlrp3 #ncx1 #kls13019 #neuro #inflammation #mitochondria
https://t.co/42QCks98hO
0
1
4
1,4 Mio € von @MichaelJFoxOrg für Chi Wang Ip @Uniklinikum_Wue & Partnern @Kannalife #Atuka. Sie untersuchen am spez. Mausmodell, ob KLS-13019, das strukturell mit Cannabinoiden verwandt ist, ein wirksames Medikament gegen #Parkinson sein könnte. https://t.co/wQwvsU4b3F
0
3
3
@Kannalife featured in @parkinsonstory - @MichaelJFoxOrg $1.49M grant to advance preclinical research into #KLS13019 - #Parkinsons #ParkinsonsResearch #Neuroinflammation #MitochondrialDysfunction #CannabinoidTherapeutic #Kannalife #MJFF
https://t.co/23GASI1c3b
parkinsonsnewstoday.com
A $1.49 million MJFF grant will support preclinical research into KLS-13019, a CBD-derived therapy targeting neuroinflammation in Parkinson's.
0
3
7
@Kannalife secures $1.49M from @MichaelJFoxOrg for #ParkinsonsResearch! This funding will boost the development of #KLS13019, addressing #neuroinflammation and #mitochondrialdysfunction. #Biotech #Innovation #CannabinoidTherapeutics #Kannalife #MJFF
https://t.co/jeblhRkKcW
globenewswire.com
Funding of $1.49 million USD to support the development of KLS-13019 targeting neuroinflammation and mitochondrial dysfunction Kannalife has...
0
3
8
@Kannlife CEO Dean Petkanas interview at @IAmBiotech #BIO2024 by Life Science Success Podcast #neuroprotection #cannabinoidtherapeutics #nlrp3 #gpcr #gpr55 #mitochondria #ncx1 #antiinflammatory
https://t.co/ynKYCiHcYU
0
2
5
@Kannalife selected by @NIH as one of 30 Companies to present at @BIOConvention in San Diego. Presentation Tues June 4, 2024 @ 4:30 PM in Company Presentation Theater 3. Plus visit us NIH booth #825 on Tues June 4 @ 11:56 AM #BIO #NIH #Kannalife #Biotech
https://t.co/mwMyfbUORF
0
2
5
Exciting times @BioNJ_Org 🧬 Dean Petkanas of @Neuropathix @Kannalife sees New Jersey as the ultimate hub for life sciences. With 50% of attendees agreeing, NJ proves it's a leader in biotech! @ROINJNews #BioNJ #LifeSciences #Biotech #Pharma #Innovation
https://t.co/hTzALg8jXV
roi-nj.com
Dean Petkanas is the CEO of prerevenue Neuropathix, a Doylestown, Pennsylvania-based company, one of 90 that came to BioNJ’s BioPartnering Conference on Tuesday looking to make connections. And, if...
0
2
8
@Kannalife #Research Alert! Uncovering link between #KLS13019 & #GPR55 receptor - promising role in reducing #inflammation from chemotherapy-induced #peripheralneuropathy. #Cannabinoid #Innovation #GPCR #CIPN #NeuroPain #Mitochondria
https://t.co/ZQn36rj5f1
0
2
7
Dean Petkanas CEO of @Neuropathix @Kannalife presenting “#KLS13019 - A Remarkable #NonOpioid Drug Discovery for the #Treatment of #NeuroPain” - Tune in on April 2, 2024 @ 11:30am EST / 8:30am PST -
us02web.zoom.us
Zoom is the leader in modern enterprise cloud communications.
0
0
0
Join @Neuropathix at the 2023 @LifeSciSummit by @NIH on Oct 11, 2023 and see our subsidiary @Kannalife selected to take the stage at the Alexandria Center for Life Science in NYC Learn more: https://t.co/Hsw22wMdL4
#Kannalife #Neuropathix #LifeSciSummit #Biotech #Innovation
1
3
8
Today is the 12 year anniversary of founding @Neuropathix subsidiary @kannalife. $NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #pain #nonopioid #opioidalternative #cannabidiol #cbd
https://t.co/Hb2SNNjykv
0
1
3
@Neuropathix CEO Dean Petkanas Interview on #ConciergeforBetterLiving with @DocRob $NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #cbd #cannabidiol #nonopioid #opioidcrisis #neuropathicpain #pain #painmanagement #NIH #HEALInitiative #opioidalternative
https://t.co/9727hduwOK
0
2
7
@Neuropathix CEO Dean Petkanas pens Op-Ed on Why Opioids controlled the Pain Management Market and What's Next. $NPTX #NPTX #Neuropathix #KLS13019 #Kannalife #opioids #opioidcrisis #pain #painmanagement #nonopioids #NIH #NINDS #HEALInitiative
https://t.co/Z4TgpgiRys
nasdaq.com
0
1
6
@Neuropathix Highlights Revenue Related to its Grant Award with NIH-NINDS $NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #pain #nonopioid #opioidalternative #cannabidiol #cbd
https://t.co/0eLlbJqMhp
0
0
3
@Neuropathix Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019 $NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #pain #nonopioid #opioidalternative #cannabidiol #cbd
https://t.co/QEHaEWGDTw
0
1
6
@Neuropathix CEO Issues New Letter to Shareholders; Updates Market on Milestones in Research and Funding $NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch
https://t.co/7jliPejSlk
0
1
5
.@Neuropathix spokesman and former #NFL Kicker Nick Lowery discusses the need for #opioidalternatives for #pain. $NPTX #NPTX #Neuropathix #kannalife #opioid #opioids #opioidepidemic #nonopioid #kls13019 #cannabinoids #cannabidiol #chronicpain
https://t.co/UaVjb1CTZx
fox5sandiego.com
In the NFL, a pain management plan has become as important as a Sunday game plan. That’s why the league now has sought the help of scientists from UC San Diego.
0
1
4